Comorbidity in in patients with relapsing-remitting multiple sclerosis
Multiple sclerosis is a chronic autoimmune inflammatory disease that affects the brain and spinal cord. The most common form of this disease according to the type of its course is relapsing-remitting multiple sclerosis. Comorbidity in multiple sclerosis is an urgent problem of modern neurology, sinc...
Saved in:
| Main Authors: | O.V. Somilo, S.O. Makarov, O.I. Kalbus |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dnipro State Medical University
2024-10-01
|
| Series: | Medičnì Perspektivi |
| Subjects: | |
| Online Access: | https://journals.uran.ua/index.php/2307-0404/article/view/313600 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis
by: Silvia Boullosa-Lale, et al.
Published: (2021-03-01) -
Clinical and Imaging Features of Familial and Sporadic Multiple Sclerosis
by: Kamal AmirAshjei Asalemi, et al.
Published: (2025-01-01) -
Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
by: Carlo Lazzaro, et al.
Published: (2025-01-01) -
Evaluation of Inflammation-Related Proteins in Multiple Sclerosis Disease with Relapses and Remissions
by: Nisa Hocaoğlu, et al.
Published: (2024-08-01) -
Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials
by: Eoin Moloney, et al.
Published: (2024-12-01)